Baclofen for liver diseases, alcoholic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Oct 2012: Trial registered, NCT01711125

The trials

NCT01711125: Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease

State
Completed
Phase
Phase 3
People
104 taking part
Started
Mar 2013
Primary completion
Jun 2017
Arms
Arm 1, Arm 2
Results
None posted
  1. 22 Oct 2012: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Baclofen 30mg, Baclofen 30mg/day, Baclofen 60mg, Baclofen 75mg/day, Fleqsuvy, Gablofen, Kemstro, Lioresal, Lyvispah, Ozobax.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.